AstraZeneca (AZN)

Sector:

Pharma and Biotech

Index:

FTSE 100

11,968.00p
   
  • Change Today:
    616.00p
  • 52 Week High: 12,086.00p
  • 52 Week Low: 9,501.00p
  • Currency: UK Pounds
  • Shares Issued: 1,550.22m
  • Volume: 1,106,141
  • Market Cap: £185,530m
  • RiskGrade: 123

Financial Analysis

Select chart: EPS | Dividend | Revenue

Key Fundamentals

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-19 24,384.00 1,548.00 103.00¢ 92.4 n/a -39% 280.00¢ 2.9%
31-Dec-20 26,617.00 3,916.00 244.00¢ 37.6 0.3 +137% 280.00¢ 3.1%
31-Dec-21 37,417.00 (265.00) 8.00¢ 1,357.4 n/a -97% 287.00¢ 2.6%
31-Dec-22 44,351.00 2,501.00 212.00¢ 66.2 0.0 +2,550% 290.00¢ 2.1%
31-Dec-23 45,811.00 6,899.00 384.00¢ 34.5 0.4 +81% 290.00¢ 2.2%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-24 50,627.27 15,463.31 657.61p 17.3 0.2 +112% 252.44p 0.0%
31-Dec-25 54,298.16 17,530.25 747.51p 15.2 1.1 +14% 264.54p 0.0%
31-Dec-26 56,979.77 19,331.02 809.16p 14.0 1.7 +8% 275.46p 0.0%

Copyright © 2024 FactSet Research Systems Inc. All rights reserved.

Price / Earnings Data

5 Yr High 5 Yr Low 5 Yr Avg Curr / Avg
Latest 97.94 35.16 341.02 0.11

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

IFRS Changes - Find Out More

Find out about IFRS and how this affects the financial infomation for all UK companies.

AstraZeneca Market Data

Currency UK Pounds
Share Price 11,968.00p
Change Today 616.00p
% Change 5.43 %
52 Week High 12,086.00p
52 Week Low 9,501.00p
Volume 1,106,141
Shares Issued 1,550.22m
Market Cap £185,530m
RiskGrade 123

AstraZeneca Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
91.03% below the market average91.03% below the market average91.03% below the market average91.03% below the market average91.03% below the market average
92.45% below the sector average92.45% below the sector average92.45% below the sector average92.45% below the sector average92.45% below the sector average
Price Trend
36.35% above the market average36.35% above the market average36.35% above the market average36.35% above the market average36.35% above the market average
75.44% above the sector average75.44% above the sector average75.44% above the sector average75.44% above the sector average75.44% above the sector average
Income
86.97% below the market average86.97% below the market average86.97% below the market average86.97% below the market average86.97% below the market average
75% below the sector average75% below the sector average75% below the sector average75% below the sector average75% below the sector average
Growth
81.84% above the market average81.84% above the market average81.84% above the market average81.84% above the market average81.84% above the market average
94.59% above the sector average94.59% above the sector average94.59% above the sector average94.59% above the sector average94.59% above the sector average

What The Brokers Say

Strong Buy 8
Buy 13
Neutral 6
Sell 0
Strong Sell 1
Total 28
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

AstraZeneca Dividends

  Latest Previous
  2nd Interim 1st Interim
Ex-Div 22-Feb-24 10-Aug-23
Paid 25-Mar-24 11-Sep-23
Amount 197.00¢ 93.00¢

Trades for 25-Apr-2024

Time Volume / Share Price
12:24 14 @ 11,968.00p
12:24 14 @ 11,976.00p
12:24 35 @ 11,976.00p
12:24 12 @ 11,976.00p
12:24 47 @ 11,976.00p

AstraZeneca Key Personnel

Chair Michel Demare

Top of Page